A recent survey of individuals with hepatitis C who inject drugs aimed to highlight the nonclinical impacts of HCV treatment. Have your patients in this population experienced improvements in quality of...
Which treatment-related manifestation has led you to change your therapeutic approach to patients with inflammatory bowel disease (IBD)? Let us know by taking our poll.
